Literature DB >> 29254107

The Five Dimensions of Parkinson's Disease Genetic Risk.

Gerhard A Coetzee1, Steven Pierce1.   

Abstract

Genome-wide association studies of Parkinson's disease have revealed polymorphic variants associated with closely mapped genes of interest. We propose here that those genes may only represent the tip of an iceberg of regulatory effects and do not necessary reflect disease relevance. To usefully interpret a risk locus, one needs to consider 5 dimensions of information, which represent the three-dimensional structure of chromatin (dimensions #1- 3), which is locally variable across time (dimension #4), and, most importantly, dependent on cell type and context (dimension #5).

Entities:  

Keywords:  GWAS; chromatin; enhancer; non-coding DNA

Mesh:

Substances:

Year:  2018        PMID: 29254107     DOI: 10.3233/JPD-171256

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  2 in total

Review 1.  Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.

Authors:  Michaela E Johnson; Benjamin Stecher; Viviane Labrie; Lena Brundin; Patrik Brundin
Journal:  Trends Neurosci       Date:  2018-10-17       Impact factor: 13.837

Review 2.  Understanding Non-Mendelian Genetic Risk.

Authors:  Gerhard A Coetzee
Journal:  Curr Genomics       Date:  2019-08       Impact factor: 2.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.